Skip to main content

COVID

Test
Probiotics Reduce COVID Symptoms and Delay Disease Among Unvaccinated
|
  • Research
  • COVID
Test
Single Vaccine Protects Against Three Deadly Strains of Coronavirus
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
|
  • Research
  • COVID
Test
A Reflection: The Official End of the COVID-19 Public Health Emergency
|
  • Clinical Care
  • Education
  • Health System
  • Research
  • Infectious Disease
  • COVID
  • Organization News
Test
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
Test
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
|
  • Research
  • COVID
  • Infectious Disease
Test
DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative
|
  • Research
  • COVID
  • Infectious Disease
Test
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
Test
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
|
  • Research
  • COVID
Test
Investigational Mucosal COVID Vaccine Protects Against Disease and Transmission
|
  • Research
  • COVID
  • Infectious Disease
Test
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers
|
  • Research
  • Infectious Disease
  • Psychiatry
  • COVID
Test
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Test
Incidence of COVID-19 was 8 Times Higher in Unvaccinated vs. Vaccinated Students
|
  • Research
  • COVID
  • Children's Health
Test
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
|
  • Research
  • Infectious Disease
  • COVID
Test
Omicron Antibodies Persist 6 Months after Moderna Vaccine Boost But Are 6 Times Lower
|
  • Clinical Care
  • Health System
  • Research
  • COVID
  • Infectious Disease
Test
Hospital Room Surfaces Pose Low Risk of Spreading SARS-CoV-2
|
  • Research
  • Infectious Disease
  • COVID
Test
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Test
Duke Physicians Discuss Details of Omicron Variant
|
  • Clinical Care
  • Health System
  • Research
  • Infectious Disease
  • COVID
Test
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
|
  • Research
  • Infectious Disease
  • COVID
Test
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
|
  • Grants/Awards
  • COVID
  • Infectious Disease
Test
Pandemic Response Shows Path For Improved Health Care in the Future
|
  • Clinical Care
  • COVID
  • Infectious Disease
  • Primary Care
Test
Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19
|
  • Research
  • Infectious Disease
  • COVID
Test
Study Will Determine Rate of COVID Heart Inflammation Among Elite Athletes
|
  • Research
  • Heart
  • COVID
Subscribe to COVID